25.03.2011

2nd Intern. Workshop 'Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of DDIs'

The 2nd International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions (DDIs) is taking place from May 1st - May 3rd at the Marbach Castle, Lake Constance, Germany. 

The 1st Workshop in May/June 2010 was a great success and combined a regulatory update on the investigation of DDIs from the European Rapporteur perspective along with a scientific update focusing on the investigation of metabolism- and transporter-based DDIs. Around 70 experts from pharmaceutical industry, CROs and drug regulatory agencies from 10 European countries and the United States participated in the 1st Workshop at Marbach Castle. Based on the detailed feedback received from the expert audience on additional areas of interest requiring future consideration, the structure and content of the present Workshop was designed.

The topics of the 2nd Marbach Castle meeting will be covered by international scientists and experts from academia, pharmaceutical companies, contract research organizations, consultancies and regulators. The program will provide a unique opportunity for scientific exchange and networking across company and organizational borders, and an opportunity to learn about the current state-of-the-art in the investigation of DDIs.


This event is organized by Exalon partners cr.appliance. The program flyer and an online registration form are available from the cr.appliance website.

[Source: cr.appliance]







<- Back to: News

© 2007 - 2011 | Exalon GmbH | Fritz-Reichle-Ring 8 | 78315 Radolfzell | Germany | Phone: +49 (0)7732.939.1650 | Fax: -.1655 | e-Mail:info@exalon.com